boehringer ingelheim glp-1 Zealand and Collaborate on Latest Development of GLP-1R/GCGR Dual Agonist Survodutide GLP-1/GIP/NPY2 Receptor Agonist MoA Revealed

At three years, 92% are off the medicine

For every approved drug application (NDA), the Orange Book lists the patents the applicant has certified as covering the drug or its approved uses, along with their expiration dates

For example, recent work has highlighted sex-based differences in the efficacy of GLP-1RAs, with male rodents showing greater reductions in ethanol intake and mesolimbic neurotransmitter activity compared to females

However, panellists also agreed that, in the absence of evidence and clear, consistent guidance, there is a need for an expert-endorsed treatment algorithm, to support clinical decision-making for adults with CKD and T2D